As the opioid epidemic continues across America, more communities are providing their law enforcement officers with the drug naloxone (sold as Narcan) to reverse overdoses. Prosecutor Joseph D. Coronato of Ocean County, NJ, discussed the profound benefits he has seen as a result of the county’s naloxone program.
As the opioid epidemic continues across America, more communities are providing their law enforcement officers with the drug naloxone (sold as Narcan®) to reverse overdoses. Prosecutor Joseph D. Coronato of Ocean County, NJ, discussed the profound benefits he has seen as a result of the county’s naloxone program.
Transcript (slightly modified)
What effect has the Narcan program had on the local police officers?
Narcan has really turned out to have several advantages. Not only are we saving the life of that individual, making a difference where you’re bringing back from the light as they almost walked into the light, but more importantly it’s changed the image of who the victim is, who that individual is. It’s somebody’s son, it’s somebody’s daughter, it’s someone’s loved one, and I think the police officers now can relate better to that.
I think the other thing is that before they were just standing around being helpless. The other people would say “do something, do something,” but there was nothing that they could do. They had to wait for either the first aid squad or EMTs to show up. Now they can actively participate, and what happens is once they do participate and they bring that person back to life, to them it’s a life-changing moment. We have acknowledged that by acknowledging that police officer for completing that event and doing a tremendous job.
It’s heartwarming to the police officer, I think it’s changed the image of the police officer, and it’s also changed the image in the police officer’s eye of that individual who almost died. So the result is that there’ve been many, many different advantages to the Narcan program besides the fact that we brought somebody from the jaws of death.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen